Postprandial lipemia--effect of lipid-lowering drugs. by Karpe, F

Handling of Chylomicrons in Human Adipose Tissue In Vivo: Consequences of Obesity by Karpe, F

Postprandial lipid metabolism in relation to coronary heart disease. by Karpe, F

Insulin resistance by adiponectin deficiency: is the action in skeletal muscle? by Karpe, F

Atherosclerosis: cell biology and lipoproteins. by Karpe, F

Effects of diet on postprandial lipaemia: A suggestion for methodological standardization by Karpe, F

Mechanisms of postprandial hyperlipidaemia--remnants and coronary artery disease. by Karpe, F

Lipid-Related Factors by Karpe, F

Chylomicron production as a feature of atherogenic lipoproteins. by Karpe, F

Genetic determinants of dietary and drug responsiveness. by Karpe, F

Heterogeneity of triglyceride-rich lipoproteins in the postprandial state by Karpe, F

Postprandial lipoprotein metabolism and atherosclerosis. by Karpe, F

MicroRNAs in adipose tissue: Their role in adipogenesis and obesity by Hilton, C, Neville, M, Karpe, F, Karpe, F

Determinants of VLDL-triglycerides production. by Nielsen, S, Karpe, F

Fatty acid, dyslipidaemia and insulin resistance - Preface by Karpe, F, Coppack, S

Adipose tissue: Fat, yet fit by Vasan, S, Karpe, F

Journal of the Royal Society of Medicine: Preface by Karpe, F, Coppack, S

Determinants of VLDL-triglycerides production by Nielsen, S, Karpe, F

Marked resistance of femoral adipose tissue blood flow and lipolysis to adrenaline in vivo by Manolopoulos, K, Manolopoulos, K, Karpe, F, Karpe, F, Frayn, K

PPARdelta in humans: genetic and pharmacological evidence for a significant metabolic function. by Karpe, F, Ehrenborg, E